メタ情報
| meta description平均長 | 176.95 |
|---|
| OGPありページ数 | 10 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 228 |
|---|
| ページあたり内部リンク平均 | 217.4 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| drugs | 1 |
| GLP | 0.929307 |
| China | 0.90309 |
| pharmaceutical | 0.898676 |
| project | 0.785714 |
| analysis | 0.714286 |
| development | 0.706207 |
| platform | 0.706207 |
| quality | 0.649044 |
| have | 0.60206 |
| Semaglutide | 0.599117 |
| Anhui | 0.588506 |
| services | 0.588506 |
| industry | 0.571429 |
| Ruxolitinib | 0.571429 |
| JAK | 0.571429 |
| thrombosis | 0.571429 |
| heart | 0.557584 |
| gastrointestinal | 0.557584 |
| ruxolitinib | 0.557584 |
| privacy | 0.557584 |
| policy | 0.557584 |
| room | 0.557584 |
| products | 0.549191 |
| use | 0.529656 |
| which | 0.522879 |
| production | 0.521065 |
| CPHI | 0.5 |
| disorders | 0.5 |
| our | 0.48553 |
| cookies | 0.464654 |
| management | 0.449338 |
| has | 0.449338 |
| used | 0.449338 |
| API | 0.430043 |
| standards | 0.428571 |
| PMEC | 0.428571 |
| apixaban | 0.428571 |
| control | 0.428571 |
| anti | 0.411954 |
| research | 0.411954 |
| one | 0.411954 |
| product | 0.410833 |
| FarmaSino | 0.399411 |
| was | 0.399411 |
| stop | 0.399411 |
| also | 0.387039 |
| can | 0.373485 |
| tons | 0.371723 |
| Year | 0.371723 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| back | soon | 4.522451 | 240 |
| Leave | Message | 4.493962 | 160 |
| call | will | 4.390033 | 240 |
| Your | message | 4.312418 | 160 |
| message | must | 4.312418 | 160 |
| between | must | 4.312418 | 160 |
| between | characters | 4.312418 | 160 |
| Please | characters | 4.295273 | 160 |
| Please | check | 4.188344 | 152 |
| call | you | 4.117357 | 240 |
| back | you | 4.117357 | 240 |
| better | facilitates | 3.855984 | 80 |
| Submitted | successfully | 3.855984 | 80 |
| better | communication | 3.797117 | 80 |
| Submitted | communication | 3.797117 | 80 |
| check | your | 3.763607 | 144 |
| mail | your | 3.748199 | 136 |
| Your | soon | 3.613772 | 160 |
| facilitates | information | 3.530185 | 80 |
| Message | will | 3.50796 | 160 |
| More | information | 3.471318 | 80 |
| characters | check | 3.365845 | 120 |
| back | call | 3.32263 | 180 |
| Your | must | 3.282026 | 120 |
| between | message | 3.282026 | 120 |
| characters | must | 3.282026 | 120 |
| Please | between | 3.267283 | 120 |
| More | mail | 3.17117 | 80 |
| check | mail | 3.171044 | 104 |
| Submitted | better | 3.042165 | 60 |
| More | facilitates | 2.991128 | 60 |
| communication | facilitates | 2.991128 | 60 |
| communication | successfully | 2.991128 | 60 |
| soon | you | 2.977694 | 180 |
| one | stop | 2.951179 | 28 |
| will | you | 2.902657 | 182 |
| Please | your | 2.848725 | 112 |
| CPHI | PMEC | 2.820058 | 24 |
| better | information | 2.7597 | 60 |
| Leave | will | 2.746378 | 120 |
| Message | call | 2.681255 | 120 |
| Your | back | 2.681255 | 120 |
| message | soon | 2.681255 | 120 |
| diabetes | type | 2.663927 | 20 |
| Economic | Suzhou | 2.592444 | 16 |
| Development | Economic | 2.592444 | 16 |
| Development | Zone | 2.592444 | 16 |
| carry | out | 2.592444 | 16 |
| Melanoma | NSCLC | 2.592444 | 16 |
| reduce | risk | 2.592444 | 16 |